SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-22-099756
Filing Date
2022-09-14
Accepted
2022-09-13 18:15:55
Documents
5

Document Format Files

Seq Description Document Type Size
1 425 tm2225658d1_8k.htm 425 50937
2 EXHIBIT 2.1 tm2225658d1_ex2-1.htm EX-2.1 44928
3 EXHIBIT 10.1 tm2225658d1_ex10-1.htm EX-10.1 40776
4 EXHIBIT 10.2 tm2225658d1_ex10-2.htm EX-10.2 51796
5 EXHIBIT 10.3 tm2225658d1_ex10-3.htm EX-10.3 22068
  Complete submission text file 0001104659-22-099756.txt   212240
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filed by) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Subject) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-36150 | Film No.: 221241715
SIC: 2836 Biological Products, (No Diagnostic Substances)